Clinical trials
Terminated Non-alcoholic Fatty Liver Disease trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2008 | 1 |
| 2010 | 2 |
| 2014 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 17 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AdventHealth Translational Research Institute | 1 |
| Axcella Health, Inc | 1 |
| Chinese University of Hong Kong | 1 |
| Emory University | 1 |
| Indiana University | 1 |
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 1 |
| Massachusetts General Hospital | 1 |
| Regeneron Pharmaceuticals | 1 |
| US Department of Veterans Affairs | 1 |
| University Hospital, Gentofte, Copenhagen | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-alcoholic Fatty Liver Disease | 17 |
| Fatty Liver | 3 |
| Fibrosis | 3 |
| Insulin Resistance | 3 |
| Obesity | 3 |
| Diabetes Mellitus, Type 2 | 2 |
| Acute Kidney Injury | 1 |
| Carcinoma, Hepatocellular | 1 |
| Chemical and Drug Induced Liver Injury | 1 |
| End Stage Liver Disease | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.